首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4
【24h】

Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4

机译:人肽基精氨酸脱亚氨酶4对组蛋白N端识别的结构基础

获取原文
获取原文并翻译 | 示例
       

摘要

Histone arginine methylation is a posttranslational modification linked to the regulation of gene transcription. Unlike other posttranslational modifications, methylation has generally been regarded as stable, and enzymes that demethylate histone arginine residues have not been identified. However, it has recently been shown that human peptidylarginine deiminase 4 (PAD4), a Ca2+-dependent enzyme previously known to convert arginine residues to citrulline in histones, can also convert monomethylated arginine residues to citrulline both in vivo and in vitro. Citrullination of histone arginine residues by the enzyme antagonizes methylation by histone arginine methyltransferases and is thus a novel posttranslational modification that regulates the level of histone arginine methylation and gene activity. Here we present the crystal structures of a Ca2+-bound PAD4 mutant in complex with three histone N-terminal peptides, each consisting of 10 amino acid residues that include one target arginine residue for the enzyme (H3/Arg-8, H3/Arg-17, and H4/Arg-3). To each histone N-terminal peptide, the enzyme induces a beta-turn-like bent conformation composed of five successive residues at the molecular surface near the active site cleft. The remaining five residues are highly disordered. The enzyme recognizes each peptide through backbone atoms of the peptide with a possible consensus recognition motif. The sequence specificity of the peptide recognized by this enzyme is thought to be fairly broad. These observations provide structural insights into target protein recognition by histone modification enzymes and illustrate how PAD4 can target multiple arginine sites in the histone N-terminal tails.
机译:组蛋白精氨酸甲基化是与基因转录调控相关的翻译后修饰。与其他翻译后修饰不同,甲基化通常被认为是稳定的,尚未鉴定出使组蛋白精氨酸残基脱甲基的酶。然而,最近显示,人肽酰精氨酸脱亚氨酶4(PAD4),一种以前已知的Ca2 +依赖性酶,可以将组蛋白中的精氨酸残基转化为瓜氨酸,也可以在体内和体外将单甲基化的精氨酸残基转化为瓜氨酸。该酶对组蛋白精氨酸残基的瓜氨酸拮抗组蛋白精氨酸甲基转移酶的甲基化作用,因此是调节组蛋白精氨酸甲基化水平和基因活性的新型翻译后修饰。在这里,我们介绍了一个与Ca2 +结合的PAD4突变体的晶体结构,该突变体与三个组蛋白N末端肽复合,每个肽由10个氨基酸残基组成,其中包括该酶的一个目标精氨酸残基(H3 / Arg-8,H3 / Arg- 17和H4 / Arg-3)。对于每个组蛋白的N末端肽,该酶诱导一个由活性部位裂口附近的分子表面上的五个连续残基组成的β-turn-like弯曲构象。其余五个残基高度无序。该酶通过可能具有共有识别基序的肽的骨架原子识别每个肽。该酶识别的肽的序列特异性被认为是相当宽的。这些观察结果为通过组蛋白修饰酶识别靶蛋白提供了结构上的见解,并说明了PAD4如何靶向组蛋白N末端尾巴中的多个精氨酸位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号